Summary
Oral administration of insulin incorporated into the wall of isobutylcyanoacrylate nanocapsule to diabetic rats induces a long-lasting normalization of their fasting glycaemia. In this study, we examined the biological action of encapsulated insulin on DNA and glycogen syntheses in Chinese hamster ovary cells transfected with the human insulin receptor gene. In the 10−11 mol/l–10−9 mol/l concentration range, encapsulated insulin elicited responses comparable to those induced by native insulin: at 10−9 mol/l, the rates of glycogen and DNA synthesis were enhanced by factors 3 and 2.5, respectively. Encapsulated insulin at 10−7 mol/l evoked receptor desensitization although it did not induce receptor down-regulation and did not alter receptor recycling for up to 6 h. Chloroquine decreased the action of native insulin on glycogen synthesis, but did not affect the dose-response characteristics of encapsulated insulin. Acid-washing of the cells after 1 h of stimulation decreased maximal insulin responsiveness and provoked a dose response curve for encapsulated insulin similar to that of the native hormone. Direct measurement of effective insulin binding activity showed that encapsulated insulin (at 10−8 and 10−7 mol/l) was withdrawn from the incubation medium 5–8 times less efficiently than native insulin. These data are in agreement with previous results showing that the polymeric wall protects encapsulated insulin from degradation. Persistence of intact encapsulated insulin inside and outside the cell may result in modifying signalling events and thus be responsible for the observed cellular desensitization.
Article PDF
Similar content being viewed by others
Abbreviations
- IR-CHO:
-
Chinese hamster ovary cells transfected with the human insulin receptor gene
- BSA:
-
bovine serum albumin
- HEPES:
-
4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid
- PBS:
-
phosphate buffered saline
References
Réach G (1991) Immunoprotected islets of Langerhans as a bioartificial pancreas. In: Pickup JC (ed) Frontiers in pharmacology and therapeutics. Biotechnology of insulin therapy. Blackwell Scientific Publications, Oxford, pp 75–96
Sullivan SJ, Maki T, Borland KM et al. (1991) Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 252: 718–721
Lassman-Vague V (1991) The intranasal route for insulin administration. In: Pickup JC (ed) Frontiers in pharmacology and therapeutics. Biotechnology of insulin therapy. Blackwell Scientific Publications, Oxford, pp 113–125
Eppstein DA, Longnecker JP (1988) Alternative delivery systems for peptides and proteins as drugs. Crit Rev Ther Drug Carrier Syst 5: 99–139
Aprahamian M, Michel C, Humbert W, Devissaguet JP, Damgé C (1987) Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell 61: 69–76
Damgé C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP (1990) Nanocapsules as carriers for oral peptide delivery. J Controlled Release 13: 233–239
Kante B, Couvreur P, Dubois-Krack G et al. (1982) Toxicity of polyalkylcyanoacrylate nanoparticles. I. Free nanoparticles. J Pharm Sci 71: 786–790
Lenaerts V, Couvreur P, Christiaens-Leyh D, Joiris E, Roland M, Rollman B, Speiser P (1984) Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials 5: 65–68
Damgé C, Michel C, Aprahamian M, Couvreur P (1988) New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37: 246–251
Roques M, Damgé C, Michel C, Staedel C, Crémel G, Hubert P (1992) Encapsulation of insulin for oral administration preserves the interactions of the hormone with its receptor in vitro. Diabetes 41: 451–456
Crestfield AM, Moore S, Stein WH (1963) The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins. J Cell Biol 238: 622–637
Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ (1986) Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45: 721–732
Leconte I, Auzan C, Debant A, Rossi B, Clauser, E (1992) N-linked oligosaccharide chains of the insulin receptor-beta subunit are essential for transmembrane signalling. J Biol Chem 267: 17415–17423
Le Marchand-Brustel Y, Ballotti R, Van Obberghen E (1988) Insulin receptor kinase activity in states with altered insulin action. In: Kahn CR, Harrison LC (eds) Insulin receptors, part A. Alan R. Liss, New York, pp 163–179
Vogt B, Carrascosa JM, Ermel B, Ullrich A, HÄring HU (1991) The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Comm 177: 1013–1018
Robertson ADJ (1987) Biphasic responses, quantal signals and cellular behavior. J Theor Biol 125: 41–60
Seals JR, Jarett L (1980) Activation of pyruvate dehydrogenase by direct addition of insulin to an isolated plasma membrane/mitochondria mixture. Proc Natl Acad Sci USA 77: 77–81
Heaton JH, Gelehrter TD (1981) Desensitization of hepatoma cells to insulin action. Evidence for a post-receptor mechanism. J Biol Chem 256: 12257–12262
Lohse MJ (1993) Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1179: 171–188
Reynet C, Caron M, Magré J et al. (1990) Mutation of tyrosine residues 1162 and 1163 of the insulin receptor affects hormone and receptor internalization. Molec Endocrinol 4: 304–311
Michel C, Aprahamian M, Defontaine L, Couvreur P, Damgé C (1991) The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. J Pharm Pharmacol 43: 1–5
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roques, M., Crémel, G., Aunis, D. et al. Biological effects of encapsulated insulin on transfected Chinese hamster ovary cells. Diabetologia 38, 180–186 (1995). https://doi.org/10.1007/BF00400092
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400092